We report a case of post-artesunate delayed haemolysis (PADH) in severe Plasmodium falciparum malaria
Background. Parenteral artesunate is recommended as first-line therapy for severe malaria. While its...
International audienceWe read with interest the article by Rehman et al. on post-artesunate hemolysi...
International audienceBackground: Parenteral artesunate is recommended as first-line therapy for sev...
As a result of a huge effort of the international community, the burden of malaria dropped impressiv...
Artesunate is the drug of choice for treating patients with severe malaria. Post-artesunate delayed ...
INTRODUCTION: Delayed haemolytic anaemia is one of the more frequent events after tr...
Malaria infection, which results due to the parasitic protozoan Plasmodium, has several known etiolo...
Abstract Parenteral artesunate has been shown to be a superior treatment option compared to parenter...
A documented side-effect of artemisinin therapy is post-artemisinin delayed hemolysis (PADH), primar...
Parenteral artesunate (AS) is the WHO first-line treatment recommended in adults and children for se...
Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with intravenous artesunat...
Episodes of delayed hemolysis 2-6 weeks after treatment of severe malaria with intravenous artesunat...
Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anem...
Malaria is a serious and sometimes fatal disease caused by an intraerythrocytic parasite, and is com...
Parenteral artesunate (AS) is the WHO first-line treatment recommended in adults and children for se...
Background. Parenteral artesunate is recommended as first-line therapy for severe malaria. While its...
International audienceWe read with interest the article by Rehman et al. on post-artesunate hemolysi...
International audienceBackground: Parenteral artesunate is recommended as first-line therapy for sev...
As a result of a huge effort of the international community, the burden of malaria dropped impressiv...
Artesunate is the drug of choice for treating patients with severe malaria. Post-artesunate delayed ...
INTRODUCTION: Delayed haemolytic anaemia is one of the more frequent events after tr...
Malaria infection, which results due to the parasitic protozoan Plasmodium, has several known etiolo...
Abstract Parenteral artesunate has been shown to be a superior treatment option compared to parenter...
A documented side-effect of artemisinin therapy is post-artemisinin delayed hemolysis (PADH), primar...
Parenteral artesunate (AS) is the WHO first-line treatment recommended in adults and children for se...
Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with intravenous artesunat...
Episodes of delayed hemolysis 2-6 weeks after treatment of severe malaria with intravenous artesunat...
Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anem...
Malaria is a serious and sometimes fatal disease caused by an intraerythrocytic parasite, and is com...
Parenteral artesunate (AS) is the WHO first-line treatment recommended in adults and children for se...
Background. Parenteral artesunate is recommended as first-line therapy for severe malaria. While its...
International audienceWe read with interest the article by Rehman et al. on post-artesunate hemolysi...
International audienceBackground: Parenteral artesunate is recommended as first-line therapy for sev...
DOI
Add to ORKG